A study on anti-diabetic prescription along with patients in Bangladeshi perspective
Department of Pharmacy, Jahangirnagar University, Dhaka-1342, Bangladesh.
Research Article
World Journal of Advanced Research and Reviews, 2023, 20(03), 1705–1712
Publication history:
Received on 21 November 2023; revised on 27 December 2023; accepted on 29 December 2023
Abstract:
Diabetes is the main cause for inability and premature death in Bangladesh. As a part of treatment, Patients may have lifestyle changes, medications, surgery or other medical procedures. The aim of current research is to seek out therapy pattern for diabetes treatment in Bangladesh. A cross sectional study was performed in the government and private hospitals situated in Dhaka. 144 prescriptions of diabetic patients are collected from BIRDEM and BIHS Diabetic Center has 77 Male patient (53.47%) and female patient number 67 (46.53%). Most prescription drugs have captured Sitagliptin 34.02%, Linagliptin 20.83%, Metformin Hydrochloride 20.13%, Gliclazide 25%. Other results of this studies are described throughout the study and discussion. This research result focused on prescription pattern, lifestyle and awareness of patients. Those who are affected and plagued by the diabetes disease should be more responsive to this aspect, because little negligence is often the main reason for their life threat.
Keywords:
Diabetes; Patients; Prescription; Lifestyle; Bangladesh; Hospital Patients
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0